NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-23
Reading KRMN? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with some volatility. The current thesis state is intact, supported by strong recent financial performance and management's focus on increasing revenue and adjusted EBITDA guidance.
The market appears to be pricing in a premium compared to peers, reflecting expectations of continued growth. However, there is an expectations gap indicating that some fragility is acknowledged, particularly due to weak execution quality.
Management is on track with their priorities, showing strong revenue and adjusted EBITDA growth. However, there is a near-term risk of missing earnings expectations, as the company has missed in recent quarters.
The thesis hinges on management's ability to meet or exceed guidance and the performance of sector bellwethers like SPCX, GE, and RTX. Any changes in guidance or performance from these companies could significantly impact KRMN's trajectory.
Overall, KRMN's performance is strong, but the elevated risks and expensive valuation warrant careful observation. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: An earnings miss can lead to negative sentiment. This could affect the stock price.
Confirms:Investor feelings get better after the earnings miss.
Disproves:Investor feelings get worse after the earnings miss.
Why it matters: An increase in revenue guidance shows management's confidence in growth. This could lead to positive investor sentiment.
Confirms:Management raises revenue guidance for 2026. This is higher than what people expected.
Disproves:Management keeps revenue guidance the same or lowers it for 2026.
Why it matters: Raising revenue guidance shows strong confidence in growth. This could boost investor sentiment.
Confirms:The company raises its revenue guidance for 2026. This is above current estimates.
Disproves:The company maintains or lowers its revenue guidance for 2026.
Why it matters: Earnings results will provide insight into revenue and profit trends. This can significantly affect stock performance.
Confirms one read:Earnings results show revenue growth exceeding 20% year over year.
Confirms the other:Earnings results show revenue growth below 10% year over year.
Why it matters: The revenue growth guidance shows Karman can turn backlog into sales.
Confirms:Management confirms Q2 revenue growth guidance of 54% compared to last year.
Disproves:Management lowers or withdraws the Q2 revenue growth guidance.
Why it matters: Good acquisitions can help growth and profits. This matters for Karman's plan.
Confirms:Karman announces an acquisition that adds at least 15% to revenue.
Disproves:Acquisitions do not help revenue or EBITDA.
Why it matters: Higher adjusted EBITDA guidance means better profits. This may bring in more investors.
Confirms:The company raises its adjusted EBITDA guidance for 2026. This is in the Q2 report.
Disproves:The company does not change its adjusted EBITDA guidance for 2026.
Why it matters: Changes in auditors can change how financial reports look. This may affect investor trust.
Confirms one read:The new auditor, PwC, gives a good report on Karman's finances.
Confirms the other:PwC is worried about Karman's money reports and internal controls.
Why it matters: Exceeding this level would show strong profits and good operations.
Confirms:Adjusted EBITDA was over $50 million for Q2.
Disproves:Adjusted EBITDA falls below $45 million for Q2.
Why it matters: A bigger backlog means strong future revenue and demand for Karman's products.
Confirms:Backlog reported above $1.1 billion at the end of Q2.
Disproves:Backlog reported below $1.0 billion at the end of Q2.
